🔬 Universitätsklinikum Tübingen sucht PostDoc - Forschung und Entwicklung im Bereich Gentherapie bei Präleukämie

• Design and conduct in vitro and in vivo experiments using gene-edited hematopoietic stem/progenitor cells
• Develop and optimize gene editing protocols for ELANE for therapeutic use
• Evaluate safety, efficacy, leukemogenicity and off-target effects of gene therapies in preclinical models
• Actively participate in the development of GMP-compatible protocols for clinical translation
• Assist in the preparation of regulatory documents and collaborate with clinical and regulatory teams to support the transition to first-in-human trials
  
  
  

• PhD or postgraduate degree with focus in cellular and molecular biology, gene editing, human stem cell biology, hematopoiesis and leukemogenesis
• Experience with gene editing technology, HSC culture, and in vivo models of blood cell disorders is highly desirable
• Experience in GMP production and clinical trial development is desirable
• Excellent analytical, organizational, and communication skills
• English proficiency required

Benefits

• A multicultural, multidisciplinary and highly motivated team
• A dynamic and supportive research environment within a leading academic institution
• Access to state-of-the-art facilities and technologies
• Opportunities for professional development and career advancement, including access to the SPARK-BIH mentoring program and participation at national and international conferences
• Close collaboration with clinical and translational research partners
• Subsidy for public transportation tickets and employee discounts